V Raymond

Author PubWeight™ 38.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet 1998 2.34
2 An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature 2009 1.42
3 A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q. Am J Hum Genet 1995 1.40
4 Rapid mRNA degradation mediated by the c-fos 3' AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3' AU-rich element occur through similar polysome-associated mechanisms. Mol Cell Biol 1995 1.35
5 Molecular genetics of the glaucomas: mapping of the first five "GLC" loci. Am J Hum Genet 1997 1.29
6 Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem 1978 1.26
7 Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol 1988 1.15
8 Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet 2001 1.12
9 Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet 1998 1.11
10 Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am J Med Genet 1995 1.00
11 Isolation of a novel iris-specific and leucine-rich repeat protein (oculoglycan) using differential selection. Invest Ophthalmol Vis Sci 2000 0.99
12 GLC-3: a novel fipronil and BIDN-sensitive, but picrotoxinin-insensitive, L-glutamate-gated chloride channel subunit from Caenorhabditis elegans. Br J Pharmacol 2001 0.98
13 Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 1978 0.98
14 5' untranslated sequences modulate rapid mRNA degradation mediated by 3' AU-rich element in v-/c-fos recombinants. Nucleic Acids Res 1992 0.98
15 Role of loop D of the alpha7 nicotinic acetylcholine receptor in its interaction with the insecticide imidacloprid and related neonicotinoids. Br J Pharmacol 2000 0.95
16 Isolation of a ubiquitin-like (UBL5) gene from a screen identifying highly expressed and conserved iris genes. Genomics 2001 0.95
17 Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett 2011 0.93
18 Mechanism of action of hypothalamic hormones in the adenohypophysis. Annu Rev Physiol 1979 0.88
19 Evidence for association and linkage between atopy, airway hyper-responsiveness, and the beta subunit Glu237Gly variant of the high-affinity receptor for immunoglobulin E in the French-Canadian population. Immunogenetics 2000 0.88
20 Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Semin Oncol 1989 0.88
21 Stimulation of phosphatidic acid and phosphatidylinositol labeling in luteal cells by luteinizing hormone releasing hormone. Endocrinology 1983 0.83
22 Parallel release of ACTH, beta-endorphin, alpha-MSH and beta-MSH-like immunoreactivities in rat anterior pituitary cells in culture. Mol Cell Endocrinol 1979 0.83
23 Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin. Biochem Biophys Res Commun 1978 0.83
24 Transcriptome of mouse uterus by serial analysis of gene expression (SAGE): comparison with skeletal muscle. Mol Reprod Dev 2004 0.83
25 Mechanism of action of hypothalamic hormones in the anterior pituitary gland and specific modulation of their activity by sex steroids and thyroid hormones. Recent Prog Horm Res 1978 0.82
26 Fibroblast growth factor stabilizes ribonucleic acid and regulates differentiated functions in a multipeptide-secreting neuroendocrine cell line. Endocrinology 1988 0.82
27 Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. Cancer Treat Rep 1986 0.82
28 LHRH rapidly stimulates phosphatidylinositol metabolism in enriched gonadotrophs. Mol Cell Endocrinol 1984 0.81
29 A balanced 2:18 translocation and familial schizophrenia: falling short of an association. Arch Gen Psychiatry 1993 0.79
30 New aspects of the control of pituitary hormone secretion. Ann Clin Res 1978 0.78
31 Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract. Cancer Treat Rep 1984 0.78
32 Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol 2004 0.78
33 Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. FEBS Lett 1985 0.77
34 Transcriptional regulation of human zeta and psi zeta globin genes. Prog Clin Biol Res 1987 0.77
35 Stimulation by prostaglandin F2 alpha of phosphatidic acid-phosphatidylinositol turnover in rat luteal cells. Biochem Biophys Res Commun 1983 0.77
36 Induction of c-fos, calcitonin gene expression, and acidic fibroblast growth factor production in a multipeptide-secreting neuroendocrine cell line. Endocrinology 1988 0.77
37 Phase II study of idarubicin in advanced cervical carcinoma. Am J Clin Oncol 1986 0.76
38 The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada. Int J Clin Pract 2014 0.76
39 Parallel stimulation of ACTH, beta-LPH + beta-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in culture. Mol Cell Endocrinol 1981 0.76
40 4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. Cancer Res 1989 0.76
41 Idarubicin in acute leukemia: results of US trials. Bone Marrow Transplant 1989 0.75
42 Phase II trial of idarubicin in patients with pancreatic cancer. Cancer Treat Rep 1987 0.75
43 Phase II study of idarubicin in advanced endometrial carcinoma. Cancer Treat Rep 1987 0.75
44 Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer. Cancer Treat Rep 1985 0.75
45 Multiple factors controlling ACTH secretion at the anterior pituitary level. Ann N Y Acad Sci 1987 0.75
46 Mechanism of action of TRH: involvement of the phosphatidylinositol (PI) response in the action of TRH in rat anterior pituitary cells. Life Sci 1982 0.75
47 Phase II trial of esorubicin in patients with advanced colorectal carcinoma. Cancer Treat Rep 1986 0.75
48 Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer. Cancer Treat Rep 1987 0.75
49 [Specific role of sex steroids on the pituitary level. Sex steroids and anterior pituitary secretion]. Bull Schweiz Akad Med Wiss 1978 0.75
50 Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer. Cancer Res 1985 0.75
51 [Control of the parallel release of ACTH, beta-endorphin + beta-LPH and their fragments in cultured adenohypophyseal rat cells]. Union Med Can 1981 0.75
52 Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma. Cancer Treat Rep 1985 0.75
53 Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion. Fed Proc 1980 0.75
54 The pituitary dopamine receptor. Adv Biochem Psychopharmacol 1980 0.75